Qrem Cytokine Analysis

Stimulate tissue repair in musculoskeletal conditions; Accelerate recovery from soft tissue injuries; Reduce inflammation in joint disorders; Provide a non-pharmaceutical treatment option; Administer in a clinical setting during initial consultations.

Main Information

• Information: Qrem is a start-up engaged in regenerative medicine that develops, manufactures, and markets medical devices. Its mission is to promote the standardization and scalability of autologous regenerative therapies, providing Lab-in-a-Box bioengineering systems and companion diagnostics (CDx) based on AI. The first product, Qrem Cytokine, has been commercialized since 2019 and involves obtaining a Cytokine Rich Serum from the patient's blood for local infiltration in treatment areas. The company is currently involved in R&D projects for knee osteoarthritis and complex wound management.
• Interests: APP/MOBILE SERVICES, ARTIFICIAL INTELLIGENCE, HEALTH/FITNESS/WELLBEING
• Location: Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B12
• Whether tagged as startup: Yes

Contact & Links

• LinkedIn: Connect on LinkedIn
• Twitter: Follow on X (formerly Twitter)
• Phone Number: Not available
• Email: Email

Key Information

• Growth Stage: Series B
• Country: Spain
• Founding Year: 2016

Company Context

• Company Name: Tecnologia Regenerativa QREM
• Company Website: https://qrem-regenerative.com/